C000220945 Performance — BlackRock LifePath ESG Index 2040 Fund, Class K
Data updated: 2026-09-25
C000220945 returned +8.73% year to date and +17.45% over one year to Jul 2026. Annualised returns are +14.46% over 3 years and +7.91% over 5 years. The fund beat its Target-Date category average: $100 invested three years ago grew to $150, against $146 for the category, and to $117 over one year, against $116. Volatility over the past three years was 10.33% a year. In the 12 months to Jul 2026 the fund took in a net $6.8M, and assets reached $31.70M.
C000220945 Growth of $100
What $100 invested in BlackRock LifePath ESG Index 2040 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | C000220945 | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $117 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $150 | $146 |
| 5 years (Aug 2021 – Jul 2026) | $146 | $142 |
| Since data start (Aug 2020 – Jul 2026) | $185 | $174 |
C000220945 Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +8.73% |
| 1 year | +17.45% |
| 3 years (annualised) | +14.46% |
| 5 years (annualised) | +7.91% |
C000220945 Annual Returns
Calendar-year total returns of BlackRock LifePath ESG Index 2040 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +8.73% |
| 2025 | +17.53% |
| 2024 | +12.72% |
| 2023 | +18.90% |
| 2022 | −17.64% |
| 2021 | +17.02% |
| 2020 (Aug–Dec) | +12.07% |
C000220945 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.4% | +1.7% | −5.2% | +7.1% | +3.3% | +0.1% | −0.6% | — | — | — | — | — |
| 2025 | +2.4% | −0.1% | −2.8% | +0.5% | +4.2% | +3.9% | +0.5% | +2.5% | +2.8% | +1.7% | +0.3% | +0.5% |
| 2024 | −0.2% | +2.9% | +2.7% | −3.0% | +3.6% | +1.5% | +2.4% | +2.2% | +2.1% | −2.5% | +3.5% | −2.8% |
| 2023 | +7.0% | −2.9% | +2.4% | +1.2% | −1.3% | +4.5% | +2.9% | −2.4% | −3.6% | −2.7% | +8.2% | +5.0% |
| 2022 | −4.6% | −2.6% | +1.3% | −7.1% | +0.3% | −7.4% | +6.8% | −4.2% | −8.9% | +5.3% | +7.5% | −3.8% |
| 2021 | −0.3% | +2.4% | +2.6% | +3.6% | +1.7% | +1.0% | +1.1% | +1.9% | −3.6% | +4.4% | −2.4% | +3.5% |
| 2020 | — | — | — | — | — | — | — | +1.4% | −2.7% | −2.0% | +11.3% | +4.2% |
C000220945 Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 10.33%
- 3-year Sharpe ratio: 0.96 (vs 4.5% risk-free rate)
- Best month: +8.19% (Nov 2023)
- Worst month: −5.18% (Mar 2026)
C000220945 Fund Flows
Monthly money in and out of BlackRock LifePath ESG Index 2040 Fund, from SEC Form N-PORT.
- 12-month net flow: $6.8M
- 12-month gross sales (incl. reinvestments): $9.5M
- Sales ÷ redemptions: 3.47×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $490K | $409K | $81K |
| Jun 2026 | $2.1M | $92K | $2.0M |
| May 2026 | $797K | $98K | $699K |
| Apr 2026 | $426K | $590K | −$164K |
| Mar 2026 | $324K | $241K | $83K |
| Feb 2026 | $329K | $63K | $266K |
| Jan 2026 | $276K | $124K | $152K |
| Dec 2025 | $682K | $70K | $612K |
| Nov 2025 | $487K | $214K | $273K |
| Oct 2025 | $1.1M | $255K | $802K |
| Sep 2025 | $229K | $360K | −$131K |
| Aug 2025 | $2.3M | $215K | $2.1M |
C000220945 Assets Under Management
Net assets of BlackRock LifePath ESG Index 2040 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $31.70M |
| 2026-04-30 | $28.17M |
| 2026-01-31 | $27.08M |
| 2025-10-31 | $25.68M |
| 2025-07-31 | $21.24M |
| 2025-04-30 | $12.12M |
| 2025-01-31 | $12.70M |
| 2024-10-31 | $10.15M |
| 2024-07-31 | $9.95M |
| 2024-04-30 | $5.30M |
| 2024-01-31 | $8.70M |
| 2023-10-31 | $6.76M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.